NCT05166616 2026-03-05
Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer
City of Hope Medical Center
Phase 1 Active not recruiting
Clinical Trials
5 trialsNCT03760523 2026-01-07
Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Terminated
NCT05557851 2022-12-09
Minnelide Along With Abraxane Plus Gemcitabine in Patients With Metastatic Adenocarcinoma of the Pancreas
Minneamrita Therapeutics LLC
Phase 1 Unknown
NCT03347994 2018-03-06
Minnelide in Adult Patients With Relapsed or Refractory Acute Myeloid Leukemia
University of Miami
Phase 1 Withdrawn
NCT01927965 2017-03-06
Study of Minnelideâ„¢ in Patients With Advanced GI Tumors
Minneamrita Therapeutics LLC
Phase 1 Completed